Traumatic spinal cord injury (TSCI) is a debilitating disease that poses significant functional and economic burden on both the individual and societal levels. Prognosis is dependent on the extent of the spinal injury and the severity of neurological dysfunction. If not treated rapidly, patients with TSCI can suffer further secondary damage and experience escalating disability and complications. It is important to quickly assess the patient to identify the location and severity of injury to make a decision to pursue a surgical and/or conservative management. However, there are many conditions that factor into the management of TSCI patients, ranging from the initial presentation of the patient to long-term care for optimal recovery. Here, we provide a comprehensive review of the etiologies of spinal cord injury and the complications that may arise, and present an algorithm to aid in the management of TSCI.
Background: Our purpose was to assess the reliability of measurements of adult-acquired flatfoot deformity (AAFD) taken by investigators of different levels of clinical experience using weightbearing computed tomography (WBCT). Methods: Nineteen AAFD patients underwent WBCT. Three investigators with different levels of clinical experience made AAFD measurements in axial, coronal, and sagittal planes. Intra-and interobserver reliability were assessed. Mean values for each measurement were compared between investigators. Results: After a training protocol, substantial to perfect intra-and interobserver reliability was observed for most measures, regardless of the investigator's experience level. Significant differences between investigators were observed in 2 of 21 measured parameters: medial cuneiform-first metatarsal angle (P = 0.003) and navicular-medial cuneiform angle (P = 0.001). Conclusions: AAFD radiographic measurements can be performed reliably by investigators with different levels of clinical experience using WBCT.
Optogenetics is an emerging bioengineering technology that has been rapidly developed in recent years by cross-integrating optics, genetic engineering, electrophysiology, software control, and other disciplines. Since the first demonstration of the millisecond neuromodulation ability of the channelrhodopsin-2 (ChR2), the application of optogenetic technology in basic life science research has been rapidly progressed, especially in neurobiology, which has driven the development of the discipline. As the optogenetic tool protein, microbial rhodopsins have been continuously explored, modified, and optimized, with many variants becoming available, with structural characteristics and functions that are highly diversified. Their applicability has been broadened, encouraging more researchers and clinicians to utilize optogenetics technology in research. In this review, we summarize the species and variant types of the most important class of tool proteins in optogenetic techniques, the microbial rhodopsins, and review the current applications of optogenetics based on rhodopsin qualitative light in biology and other fields. We also review the challenges facing this technology, to ultimately provide an in-depth technical reference to support the application of optogenetics in translational and clinical research.
Avascular osteonecrosis (AVN) of the talus (AVNT) is a painful and challenging clinical diagnosis. AVNT has multiple known risk factors and etiologies and presents at different stages in severity. Given these unique factors, the optimal treatment solution has yet to be determined. Both joint-preserving and joint-sacrificing procedures are available, including core decompression and arthrodeses. Recently, new salvage and replacement techniques have been described including vascularized pedicle bone grafts and total talus replacement using patient-specific prosthesis; however, evidence remains limited. This review examines the current trends AVNT treatment and the emerging data behind these novel techniques.
Background: Direct lateral (transpsoas) lumbar interbody fusion (LLIF) reportedly achieves union by 1 year postoperatively, but how soon fusion occurs after these minimally invasive procedures is unclear. This study investigated LLIF fusion progression at 6 months and 1 year in a large-scale cohort using bone morphogenetic protein (BMP) graft and examined risk factors associated with failed fusion.Methods: Patients undergoing primary LLIF with a single surgical team from 2015 through 2016 with polyetheretherketone (PEEK) iimplants and BMP graft were identified. Retrospective chart review included demographics and medical history, construct length and location, and concurrent L5-S1 fusion. Inclusion criteria included minimum 1-year follow-up and postoperative lumbar computed tomography at 6 months and 1 year, which was independently assessed for bony union at each level.Results: 166 patients underwent LLIF at a total of 312 levels. Seventy-nine patients (48%) underwent 1-level fusion; 45 (27%), 2 levels; and 42 (25%), 3 or more levels. At 6 months, 160 (51%) levels showed fusion. At 1 year, 70% of the remainder were fused, and total fusion rate was 85%. Fusion rates from L1 through L4 were similar (84%-87%). Nonunion was not significantly associated with construct length (P ¼ .19), concurrent anterior L5-S1 interbody fusion (P ¼ .50), age (P ¼ .70), BMI (P ¼ .15), or comorbidities such as diabetes (P ¼ .86) or thyroid disease (P ¼ .46).Conclusions: This large retrospective cohort study corroborates prior 1-year LLIF fusion rate reports (85%) independent of construct length or location or medical comorbidities. Significantly, half showed fusion by 6 months, earlier than previously described and validating the efficacy of LLIF.Level of Evidence: 5.Clinical Relevance: This study presents a large cohort of patients to support effective lumbar fusion after LLIF with BMP-2.
Background:The human shoulder joint is the most mobile joint in the body. While in vivo shoulder kinematics under minimally loaded conditions have been studied, it is unclear how glenohumeral cartilage responds to high-demand loaded exercise.Hypothesis:A high-demand upper extremity exercise, push-ups, will induce compressive strain in the glenohumeral articular cartilage, which can be measured with validated magnetic resonance imaging (MRI)–based techniques.Study Design:Descriptive laboratory study.Methods:High-resolution MRI was used to measure in vivo glenohumeral cartilage thickness before and after exercise among 8 study participants with no history of upper extremity injury or disease. Manual MRI segmentation and 3-dimensional modeling techniques were used to generate pre- and postexercise thickness maps of the humeral head and glenoid cartilage. Strain was calculated as the difference between pre- and postexercise cartilage thickness, normalized to the pre-exercise cartilage thickness.Results:Significant compressive cartilage strains of 17% ± 6% and 15% ± 7% (mean ± 95% CI) were detected in the humeral head and glenoid cartilage, respectively. The anterior region of the glenoid cartilage experienced a significantly higher mean strain (19% ± 6%) than the posterior region of the glenoid cartilage (12% ± 8%). No significant regional differences in postexercise humeral head cartilage strain were observed.Conclusion:Push-ups induce compressive strain on the glenohumeral joint articular cartilage, particularly at the anterior glenoid. This MRI-based methodology can be applied to further the understanding of chondral changes in the shoulder under high-demand loading conditions.Clinical Relevance:These results improve the understanding of healthy glenohumeral cartilage mechanics in response to loaded upper extremity exercise. In the future, these methods can be applied to identify which activities induce high glenohumeral cartilage strains and deviations from normal shoulder function.
To evaluate interobserver reliability among readers of different clinical experience by applying measurements for adult acquired flatfoot deformity (AAFD) using high-resolution three-dimensional (3D) weightbearing (WB) cone-beam CT (CBCT) examination. Methods: In this IRB approved study, 20 patients with flexible AAFD [12 male, 8 female; mean age 54.2 (20-88) years] were scanned with standing (weightbearing) CTs. Two blinded observers, a medical student and a foot/ankle surgeon, applied validated AAFD measurements in sagittal, coronal, and axial planes using predefined anatomical landmarks. Interobserver reliability was calculated using Pearson correlation. Results: There was significant interobserver agreement with high correlation for the following measurements(p < 0.0001): distances between medial cuneiform to-floor (r=0.981) and to-skin (r=0.986), navicular to-floor (0.992) and to-skin (r=0.900); cuboid to-floor (r=0.975) and to-skin (r=0.978), and calcaneus-to-fibula (r=0.808); calcaneal inclination angle (r=0.795); forefoot arch angle (r=0.983); and subtalar horizontal angles at 25%, 50%, and 75% of the anteroposterior joint length (r=0.784, 0.891, 0.809). Significant agreement with moderate correlation was additionally demonstrated for talar-first metatarsal angle (r=0.553, p < 0.014), medial cuneiform-first metatarsal angle (r=0.668, p < 0.001), and navicular-cuneiform angle (r=0.746, p < 0.0002). Level of training did not influence the reliability of any measurements except medial cuneiform-first metatarsal angle (specialist: 8.83°; student: 1.61°; p < 0.01). Statistically insignificant difference between readers (p>0.05) was noted in mean talar-first metatarsal and subtalar horizontal angles. Conclusion: While literature describes large variability for AAFD measurements from plain radiographs among readers of varying medical experience, 3D WB CBCT can yield similar measurements using predefined planes with high reliability, independent of reader experience.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.